BioNTech Investor Day Presentation Deck

3 Pandemic preparedness An integrated, multi-faceted model for future pandemic preparedness Ur Field-based testing A Laboratory testing PREPAREDNESS II Risk prediction (Al driven) M Manufacturing Planning for deployment IN Response H LATNI NUA CAR Pandemic prep. Our goal: Enable end-to-end manufacturing and delivery of our vaccines world-wide, whilst ensuring quality of production Pandemic preparedness contract with German Federal Ministry of Health in April 2022 For the next five years: reserve and maintain manufacturing capabilities to produce at least 80 million mRNA-based vaccine doses per year BIONTECH 81

View entire presentation